SK

Susanta Kumar Senapati

Active Director Director DIN 10973766
DIN 10973766 First appointment Feb 2025 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Susanta Kumar Senapati

Data last updated:

Susanta Kumar Senapati is a Director at Lkseas Pharma Private Limited (since 2025). The company operates in Research & Development.

DIN 10973766
Primary Designation Director
Industry Research & Development
First Appointment 27 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lkseas Pharma Private Limited U73100KA2025PTC198746
Director27 Feb 20252025Active

Board colleagues of Susanta Kumar Senapati

NameDINCompanyDesignation
Sitarani Swain10973767Lkseas Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lkseas Pharma Private Limited
Premium access

Shareholding and investment profile for Susanta Kumar Senapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Susanta Kumar Senapati

Susanta Kumar Senapati currently holds 1 directorship: Lkseas Pharma Private Limited (Director, since 27 Feb 2025).

Susanta Kumar Senapati was first appointed on 27 Feb 2025 as Director at Lkseas Pharma Private Limited.

The current boards of Susanta Kumar Senapati's companies include Sitarani Swain (Lkseas Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available